Stocktoria
Black Diamond Therapeutics, Inc. BDTX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-01-30
Black Diamond Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,217,128 | $15.0M | 5.59% |
| RENAISSANCE TECHNOLOGIES LLC | 1,962,394 | $3.6M | 3.41% |
| D. E. Shaw & Co., Inc. | 157,340 | $291,079 | 0.27% |
| CITADEL ADVISORS LLC | 151,000 | $279,350 | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 42,000 | $77,700 | 0.07% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.